Title: Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
Authors: Siedner MJ, Moorhouse MA, Simmons B, de Oliveira T, Lessells R, Giandhari J, Kemp SA, Chimukangara B, Akpomiemie G, Serenata Cm, Venter WDF, HillA, Gupta RK.
Journal: Nature Communications,https://doi.org/10.1038/s41467-020-19801-x: (2020)
Citation: Siedner MJ, Moorhouse MA, Simmons B, de Oliveira T, Lessells R, Giandhari J, Kemp SA, Chimukangara B, Akpomiemie G, Serenata Cm, Venter WDF, HillA, Gupta RK. Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase Nature Communications,https://doi.org/10.1038/s41467-020-19801-x: (2020).
KRISP produces over 1000 HIV-1 genomes in record time - SAMRC Press Release - 2020-12-03
Durban, 3 December 2020. The KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal has produced over 1000 HIV-1 genomes in record time in South Africa, a significant scientific endeavor to understand how drug resistance has developed to a new and potent antiretroviral (ARV) treatment.
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira